Results: 5570

For: Publication types

Who gets included in psychedelics research? A systematic review of ethnoracial representation

Picture,Image,Collage,Of,Human,Arm,Person,Against,Racism,Stop

Despite psychedelics’ roots in Indigenous and minoritised communities, clinical trials overwhelmingly centre White participants. This review highlights the consequences and asks how research can change.

[read the full story...]

Psychedelics and Queerness: Do we have a meaningful voice?

Seamless rainbow pattern with stars and sprinkles on dark background. Cute hand drawn design for kids wallpaper, textile, wrapping paper, prints.

Despite psychedelics’ deep ties with queer culture, research often excludes queer voices. This recent scoping review highlights gaps and shows how inclusive, intersectional methods can transform the field.

[read the full story...]

The genetic link behind sleep problems, cognitive dysfunction, and neuroticism in ‘treatment-resistant depression’

feat

A big new study suggests that certain genetic traits—like insomnia risk and neuroticism—may make depression harder to treat, while protective traits include education and cognitive ability.

[read the full story...]

Targeting teenage worry: network analysis of anxiety symptoms over time

cassidy-james-blaede-kfzzDJB9qHg-unsplash

Nervousness, irritability, excessive worry, uncontrollable worry… not all anxiety symptoms weigh the same at different ages. This new Chineses study shows how anxiety networks tighten as young people grow older, and where the best intervention targets may lie.

[read the full story...]

Closing the care gap: Why so few people with mental disorders receive effective treatment worldwide

alyssia-wilson-8O0_aFy72KY-unsplash

Effective treatment for mental health disorders remains the exception rather than the rule. A new 21-country study reveals where in the treatment cascade people are most likely to drop out and which factors improve the odds of getting the care they need.

[read the full story...]

“It’s not just for attention”: New research highlights the increased risk of PMDD in women with ADHD

With better public and clinician education,  timely assessment and intervention could bypass several years of diagnostic and interventional delay, for women with ADHD and PMDD.

Women with ADHD are up to 4 times more likely to experience severe premenstrual mood symptoms than those without ADHD, especially if they also live with depression or anxiety. This new UK study shines a light on a neglected area of research, and calls for better awareness, assessment, and support.

[read the full story...]

Under the skin: How childhood maltreatment may trigger lifelong multimorbidity

feat

Why do people who were maltreated as children face higher risks of both mental and physical illness? A new Mendelian randomisation study suggests that metabolic markers — like triglycerides and blood sugar — may be part of the chain connecting adversity to later multimorbidity.

[read the full story...]

Core beliefs in psychosis: new insights from a systematic review

A person gazing up at something out of shot

Negative core beliefs like “I’m worthless” or “people can’t be trusted” are linked to hallucinations, paranoia, and suicidality. This new systematic review shows how deep-rooted schemas shape psychosis, and what this means for psychological therapies.

[read the full story...]

Housing as care: Building recovery pathways for homeless women with severe mental illness

Featured

Fragmented systems leave many homeless women with severe mental illness excluded from care, re-traumatised, and at risk. This study developed a gender-sensitive housing model that integrates tertiary care, transitional homes, and community reintegration; centring dignity, safety, and recovery.

[read the full story...]

Pragmatic prescribing: why GPs offer beta-blockers for anxiety, despite guideline gaps

GPs’ perceived benefits of beta-blockers for anxiety underscore a need for further research and updated clinical guidance to align practice with evidence.

Beta-blockers like propranolol are being prescribed more often for anxiety in UK primary care, even though they don’t appear in national guidelines. This new qualitative study explores why GPs turn to them, and what that says about evidence, safety, and patient choice.

[read the full story...]